| Deadline |
Funding Opportunity |
Sponsor |
Amount |
Description |
| June 5, 2013 (standard dates apply) |
Translational Research at the Aging/Cancer Interface (TRACI) (R01) |
NIH/NCI/NIA |
Budgets are not limited |
This FOA encourages translational research proposals in the overlapping areas of human aging and cancer, linking basic and clinical research relevant to the care of older cancer patients through both bench-to-bedside and bedside-to-bench approaches. |
| June 5, 2013 (RO1) June 16 (R21) |
Mechanisms of Alcohol-associated Cancers (R01, R21) |
NIH/NIAAA/NCI |
R01: no limit; R21: combined budget for direct costs must not exceed $275,000 for 2 years |
This Funding Opportunity Announcement (FOA) invites applications from researchers with broad ranges of expertise to study the mechanisms by which alcohol increases cancer risk. |
| June 16, 2013 |
NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21) |
NIH/NCI |
Combined budget for direct costs not to exceed $275,000 |
This FOA supports the development of new research activities in all areas of cancer research. |
| June 16, 2013 |
NIC Small Grants Program for Cancer Research (NCI Omnibus R03) |
NIH/NCI |
$50,000 per year for 2 years |
This FOA supports small research projects on cancer that can be carried out in a short period of time with limited resources. |
| June 16, 2013 |
Pilot Studies in Pancreatic Cancer (R03) |
NIH/NCI |
$50,000 per year for 2 years |
Focus is for projects to promote innovative research across multiple disciplines for a better understanding of the biology, etiology, detection, prevention, and treatment of pancreatic cancer. |
| June 16, 2013 |
Pilot Studies in Pancreatic Cancer (R21) |
NIH/NCI |
$275,000 for 2 years |
This FOA encourages the submissions that propose to promote innovative research across multiple disciplines for a better understanding of the biology, etiology, detection, prevention, and treatment of pancreatic cancer. |
| June 20, 2013 |
Basic Cancer Research in Cancer Health Disparities (U01) |
NIH/NCI |
Applications may request up to $250,000 direct costs per year, and may not exceed 5 years. |
This FOA encourage grant applications from investigators interested in conducting basic, mechanistic research into the biologic/genetic causes of cancer health disparities. |
| June 20, 2013 |
Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21) |
NIH/NCI |
$275,000 for 2 years |
This FOA invites grant applications from investigators interested in conducting basic research studies into the biological causes and mechanisms of cancer health disparities. |
| June 20, 2013 |
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21) |
NIH/NCI |
$275,000 for 2 years |
This FOA invites applications by investigators from diverse backgrounds underrepresented in basic and biomedical cancer research. The NIH recognizes a unique and compelling need to promote diversity in the NIH-funded research workforce. |
| INTERNAL COMPETITION deadline: June 20, 2013 |
V Scholar Award |
V Foundation for Cancer Research |
$200,000 |
These grants are designed to identify, retain, and further the careers of talented young investigators who are pursuing independent research careers in basic cancer research. |
| July 10, 2013 |
NEW: Imaging and Biomarkers for Early Cancer Detection (R01) |
NIH/NCI |
Budgets are not limited. Max project period is 5 years |
This Funding Opportunity Announcement (FOA) invites research project (R01) applications that combine imaging and biomarkers. |
| July 10, 2013 |
NEW: Detection of Pathogen-Induced Cancer (DPIC, R01) |
NIH/NCI |
Budgets are not limited. Max project period is 5 years |
This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), is to encourage research projects which focus on the interactions of carcinogenic pathogens with the human microbiome and the host for the detection of pathogen-induced cancer (DPIC). |
| Jul 19; Dec. 16 2013 |
Cancer Prevention Research Small Grant Program (R03) |
NIH/NCI |
$200,000 |
The National Cancer Institute (NCI) invites applications that propose small and time-limited projects pertinent to the development of cancer chemoprevention agents, biomarkers for early cancer detection, cancer-related nutrition science, and/or clinical prevention studies that focus on specific target organs |
| LOI due Oct. 14, 2013 |
NEW: The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01) |
NIH/NCI |
Budgets are not limited |
This Funding Opportunity Announcement (FOA) encourages preclinical and clinical research that will describe the effect of microbially generated metabolites in cancer prevention/ progression and the molecular mechanisms underlying these effects. |